FindTrial
Sign In

A study to know the effects of magnesiun sulphate and fentanyl in spinal anesthesia.

Comparison of subarachnoid magnesium sulphate and fentanyl as adjuvants with 0.5% heavy bupivacaine for post operative analgesia in infraumbilical surgeries.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/03/041477
Enrollment
60
Registered
2022-03-30
Start date
Unknown
Completion date
Unknown
Last updated
2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K929- Disease of digestive system, unspecified

Interventions

Intervention1: Bupivacaine: 15 mg in subarachnoid space in subarachnoid block Control Intervention1: Magnesium surface, Fentanyl: Magnesium surface 100 mg in subarachnoid space as adjuvant local anaes

Sponsors

Mayo institute of medical sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Consent for participation in the study Both sex Age 18 to 55 years ASA grade 1 and 11 Infraumbilical surgeries.

Exclusion criteria

Exclusion criteria: Refusal for participation in the study ASA Grade above III History of any drug allergies Opioid addicts Anatomical spinal deformities/malformations Any chronic comorbidity Any acute URTI or fever

Design outcomes

Primary

MeasureTime frame
1. Block characteristics 2. Hemodynamic stability in intra and post-operative phase 3. Post-operative requirement of rescue analgesia and its doseTimepoint: 12-18 weeks—

Secondary

MeasureTime frame
Onset and regression of sensory and motor blocksTimepoint: 14-20 weeks—

Countries

India

Contacts

Public ContactGagandeep Kaur

Mayo institute of medical sciences

drdevendranegi@gmail.com9415003178

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026